Alterity Therapeutics Limited Profit Margin

Alterity Therapeutics Limited (ATH.AX) currently reports a profit margin of -689.83% as of June 2026. That compares with -1355.66% in the prior-year period — up 49.1% year over year. That is below the Healthcare sector average of 9.48%. Use the charts on this page to explore Alterity Therapeutics Limited's profit margin history and peer comparisons.

Alterity Therapeutics Limited's profit margin increased from -1355.66% to -689.83% — a 49.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Alterity Therapeutics Limited's profit margin of -689.83% is lower than the Healthcare sector average of 9.48%. That is roughly 7376.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Alterity Therapeutics Limited's current -689.83% should be judged against Healthcare norms (sector average: 9.48%) and against ATH.AX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -689.83%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 9.48%. From there, open related valuation or income-statement pages for Alterity Therapeutics Limited, and consider following ATH.AX for alerts when major investors trade the stock.